|
You are here |
thepsychedelicscientist.com | ||
| | | | |
www.samwoolfe.com
|
|
| | | | | Dr Robin Carhart-Harris is a neuropsychopharmacologist (or a 'scientist' if you want to be more general) who works at Imperial College London. In the past, he worked under David Nutt, the former chairman of the Advisory Council on the Misuse of Drugs. Nutt was fired for being a bit nutty (in the eyes of the... | |
| | | | |
www.sciencesummarized.com
|
|
| | | | | [AI summary] A blog post discusses the potential of psilocybin therapy as a revolutionary treatment for mental health conditions like depression and OCD, supported by recent studies and FDA approval for clinical trials. | |
| | | | |
www.nationalelfservice.net
|
|
| | | | | Kirsten Lawson focuses on novel and emerging pharmacotherapy and neuromodulation for people with 'treatment resistant depression'. | |
| | | | |
www.health.harvard.edu
|
|
| | | You may have heard of the "placebo effect," in which people taking an inactive drug as part of a study actually experience an improvement in their symptoms. As it turns out, the placebo effect still exists if you tell people they're taking a placebo. This "open-label placebo" strategy doesn'... | ||